New branch in Spain: IGES Pharma now with locations in eight European countries

Further growth of the IGES Group – Consulting services for the pharmaceutical markets in Europe: EU4+UK and beyond

Berlin, 10 April 2025 (IGES Institute) – The IGES Group is further expanding its presence in Europe by opening a branch in Spain. Since March 2025, the new office in Barcelona has been offering strategic and market access consulting services for developers and manufacturers of pharmaceuticals with a focus on the Spanish market and Portugal. IGES Italy Pharma Consulting was only founded at the start of the year.

The IGES Group now has a service network for clients in the life sciences sector that spans eight countries with its own locations in Europe. Under the umbrella of IGES Pharma, it provides market launch and reimbursement support for novel pharmaceutical developments in Europe.

The Director of the IGES Group, Professor Dr Bertram Häussler, commented: "As a strategic partner with branches or subsidiaries in eight European countries, we cover the entire spectrum of market access consulting – from initial strategy development to the complete roll-out of a product launch. Our clients benefit from consulting expertise in a coordinated network and from customized solutions from a single source for the largest pharmaceutical markets in Europe."

The Spanish branch is run by the general manager, Chus Castillo Gutierrez, who previously held senior positions in market access consulting for international pharmaceutical, medtech and biotech companies with the consulting firm Alira Health. He also has extensive experience working in companies in the biopharmaceutical sector in management committee positions such as Amgen, Viatris or Roche. He is a qualified biologist and pharmacist and has extensive knowledge in the field of early market access and the lifecycle management of innovations.

The IGES Group: from information to innovation

The IGES Group is a network of research and consulting companies in Europe specialising in the field of healthcare and market access for health innovations in the international life sciences industries. The core of the group is the IGES Institute, founded in 1980, which works on issues relating to European healthcare systems and is now one of the largest private-sector companies in this field in Germany. The IGES Group has a workforce of more than 200 highly qualified individuals in eight countries in Europe. In 2025, the IGES Group joined the athagoras Group, which draws together companies from the fields of regulatory affairs, pharmacovigilance, real world data and IT.